Add To...

    NURO  Neurometrix Inc.

    Exchange

    NASDAQ

    Sector

    Health Care

    Industry

    Medical/Dental Instruments

    Market Cap.

    4.3M

    Very Strong Balance Sheet

    NURO has more Cash than its Total Liabilities, resulting in $1.86 Net Cash per share. In other words, if you buy NURO today, the price you're paying for shares is actually $0.05 because $1.86 of Cash is included in the current share price. This much Cash is very healthy. It can help NURO sustain itself in the face of any economic turmoil and makes a stock buyback more of a possibility.
    Figures in USD. Fiscal year ends in December
    2002200320042005200620072008200920102011
    Cash 2.70M 1.62M 20.51M 32.25M 40.32M 29.72M 19.80M 30.43M 16.99M 10.29M
    Current Assets 4.72M 4.89M 25.74M 40.32M 52.78M 42.02M 29.64M 38.86M 21.68M 13.50M
    Total Assets 7.05M 7.22M 37.95M 42.90M 55.71M 56.37M 31.38M 40.57M 23.07M 14.22M
    Current Liabilities 992,492.00 2.13M 3.24M 5.63M 10.89M 8.72M 8.01M 4.48M 2.66M 3.01M
    Total Liabilities 46.98M 52.72M 3.90M 6.65M 12.30M 9.64M 8.55M 4.86M 2.87M 3.13M
    Stockholder' Equity -39.93M -45.50M 34.06M 36.25M 43.41M 46.73M 22.83M 35.71M 20.20M 11.09M
    Current Ratio 4.75 2.29 7.95 7.16 4.85 4.82 3.70 8.67 8.16 4.48
    TL-to-TA 6.66 7.30 0.10 0.15 0.22 0.17 0.27 0.12 0.12 0.22

    Low or No Reinvestment of Profits over the past 10 years

    NURO has either been retaining a small amount of their earnings or has done so inconsistently. A lack of consistency could be due to NURO operating at a loss or them having such a strong economic moat they feel comfortable spending profits on growth. Be wary of future prospects and if applicable, inspect the moat's sustainability.
    Figures in USD. Fiscal year ends in December
    2002200320042005200620072008200920102011
    Retained Earnings -39.86M -44.90M -57.48M -56.54M -53.69M -62.07M -89.80M -101.71M -118.60M -128.59M
    Retained Earnings Growth - -12.65% -28.01% 1.63% 5.05% -15.61% -44.68% -13.27% -16.61% -8.42%